These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27107247)

  • 1. Pre-study and in-study validation of a size-exclusion chromatography method with different detection modes for the analysis of monoclonal antibody aggregates.
    Oliva A; Fariña JB; Llabrés M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():206-212. PubMed ID: 27107247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitting bevacizumab aggregation kinetic data with the Finke-Watzky two-step model: Effect of thermal and mechanical stress.
    Oliva A; Llabrés M; Fariña JB
    Eur J Pharm Sci; 2015 Sep; 77():170-9. PubMed ID: 26091571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capability measurement of size-exclusion chromatography with a light-scattering detection method in a stability study of bevacizumab using the process capability indices.
    Oliva A; Llabrés M; Fariña JB
    J Chromatogr A; 2014 Aug; 1353():89-98. PubMed ID: 24786652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of high-molecular-weight nonnative aggregates and aggregation kinetics by size exclusion chromatography with inline multi-angle laser light scattering.
    Li Y; Weiss WF; Roberts CJ
    J Pharm Sci; 2009 Nov; 98(11):3997-4016. PubMed ID: 19283773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity.
    Gabrielson JP; Brader ML; Pekar AH; Mathis KB; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2007 Feb; 96(2):268-79. PubMed ID: 17080424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics.
    Bansal R; Gupta S; Rathore AS
    Pharm Res; 2019 Aug; 36(11):152. PubMed ID: 31463609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection.
    Hartmann WK; Saptharishi N; Yang XY; Mitra G; Soman G
    Anal Biochem; 2004 Feb; 325(2):227-39. PubMed ID: 14751257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of protein aggregation, degradation, and absolute molecular weight by size exclusion chromatography-multiangle laser light scattering.
    Ye H
    Anal Biochem; 2006 Sep; 356(1):76-85. PubMed ID: 16839514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering.
    Ahrer K; Buchacher A; Iberer G; Josic D; Jungbauer A
    J Chromatogr A; 2003 Aug; 1009(1-2):89-96. PubMed ID: 13677648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of uncertainty in size-exclusion chromatography with a double detection system (light-scattering and refractive index).
    Oliva A; Llabrés M; Fariña JB
    Talanta; 2009 May; 78(3):781-9. PubMed ID: 19269428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size exclusion chromatography with evaporative light scattering detection as a method for speciation analysis of polydimethylsiloxanes. II. Validation of the method for analysis of pharmaceutical formulations.
    Mojsiewicz-Pieńkowska K
    J Pharm Biomed Anal; 2011 Dec; 56(4):851-8. PubMed ID: 21840148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of capillary size exclusion chromatography for the analysis of monoclonal antibody fragments extracted from human vitreous humor.
    Rea JC; Lou Y; Cuzzi J; Hu Y; de Jong I; Wang YJ; Farnan D
    J Chromatogr A; 2012 Dec; 1270():111-7. PubMed ID: 23177154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation stability of a monoclonal antibody during downstream processing.
    Arosio P; Barolo G; Müller-Späth T; Wu H; Morbidelli M
    Pharm Res; 2011 Aug; 28(8):1884-94. PubMed ID: 21448757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size exclusion chromatography with Corona charged aerosol detector for the analysis of polyethylene glycol polymer.
    Kou D; Manius G; Zhan S; Chokshi HP
    J Chromatogr A; 2009 Jul; 1216(28):5424-8. PubMed ID: 19501366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
    He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
    J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cosolutes in the aggregation kinetics of monoclonal antibodies.
    Nicoud L; Sozo M; Arosio P; Yates A; Norrant E; Morbidelli M
    J Phys Chem B; 2014 Oct; 118(41):11921-30. PubMed ID: 25243487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel chromatography and in situ scattering to interrogate competing protein aggregation pathways.
    Gomes D; Kalman RK; Pagels RK; Rodrigues MA; Roberts CJ
    Protein Sci; 2018 Jul; 27(7):1325-1333. PubMed ID: 29717515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.